BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Latest reported BBIO revenue for 2026-06-30 was $438.2M. Net income was -$322.4M. BBIO currently screens at market cap $13.24B.
Use this BBIO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the BBIO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the BBIO SEC filings page. Lician reads the product cache first so this HTML stays unique to BridgeBio Pharma Inc even when a live quote feed is slow.
Latest cached year on this hub. Full BBIO income, balance, and cash tables.